Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.58 |
| ▸ | CES1 | P23141 | 1/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | MIF | P14174 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2202711 | 0.97 | CES2 (0.53) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL573198 | 0.92 | CES2 (0.50) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL2201861 | 0.90 | SMN1; SMN2 (0.54) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL28675379 | 0.87 | CES2 (0.46) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL28844071 | 0.87 | SMN1; SMN2 (0.48) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL6415561 | 0.87 | CES2 (0.46) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL248821 | 0.85 | CES2 (0.55) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL11862575 | 0.85 | CES2 (0.55) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL6939791 | 0.85 | CES2 (0.55) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL776566 | 0.85 | CES2 (0.55) | CES2CES1HDAC8HDAC6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11976034-B2 | Process for the production of diacyl peroxides | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-05-07 | — | — | US | claimed |
| CN-114127045-B | Method for producing diacyl peroxide | 诺力昂化学品国际有限公司 | 2023-10-13 | — | — | CN | claimed |
| EP-3983370-B1 | PROCESS FOR THE PRODUCTION OF DIACYL PEROXIDES | NOURYON CHEMICALS INT BV (NL) | 2023-08-02 | — | — | EP | claimed |
| US-20220235003-A1 | PROCESS FOR THE PRODUCTION OF DIACYL PEROXIDES | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-07-28 | — | — | US | claimed |
| EP-3983370-A1 | PROCESS FOR THE PRODUCTION OF DIACYL PEROXIDES | Nouryon Chemicals International B.V. (NL) | 2022-04-20 | — | — | EP | claimed |
| CN-114127045-A | Process for the production of diacyl peroxides | 诺力昂化学品国际有限公司 | 2022-03-01 | — | — | CN | claimed |
| WO-2020249691-A1 | PROCESS FOR THE PRODUCTION OF DIACYL PEROXIDES | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2020-12-17 | — | — | WO | claimed |
| US-7740826-B2 | Method for functionalizing carbon nanotubes utilizing peroxides | WILLIAM MARSH RICE UNIVERSITY (US) | 2010-06-22 | — | — | US | claimed |
| US-20090306427-A1 | Chemical Functionalization of Carbon Nanotubes | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2009-12-10 | — | — | US | claimed |
| EP-1989143-A1 | CHEMICAL FUNCTIONALIZATION OF CARBON NANOTUBES | National Research Council of Canada (CA) | 2008-11-12 | — | — | EP | claimed |
| WO-2007098578-A1 | CHEMICAL FUNCTIONALIZATION OF CARBON NANOTUBES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2007-09-07 | — | — | WO | claimed |
| US-20070098620-A1 | Method for functionalizing carbon nanotubes utilizing peroxides | WILLIAM MARSH RICE UNIVERSITY (US) | 2007-05-03 | — | — | US | claimed |
| US-20040223900-A1 | Method for functionalizing carbon nanotubes utilizing peroxides | WILLIAM MARSH RICE UNIVERSITY (US) | 2004-11-11 | — | — | US | claimed |
| US-3932420-A | Process for the preparation of glaziovine | ROUSSEL-UCLAF (FR) | 1976-01-13 | — | — | US | claimed |
| JP-1113413-A | — | — | None | — | — | JP | disclosed |
| JP-63235310-A | — | — | None | — | — | JP | disclosed |
| US-20260071013-A1 | COMPOSITION CONTAINING FLUORINE-CONTAINING POLYMER, METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER, AND ULTRAVIOLET LIGHT-EMITTING ELEMENT LENS CONTAINING FLUORINE-CONTAINING POLYMER | DAIKIN INDUSTRIES, LTD. (JP) | 2026-03-12 | — | — | US | disclosed |
| US-4391923-A | Low density closed-cell foamed articles from ethylene copolymer/vinyl or vinylidene halide blends | E. I. DU PONT DE NEMOURS & CO. (US) | 1983-07-05 | — | — | US | disclosed |
| US-4334035-A | ALSO CONTAINING A COPOLYMERIZABLE UNSATURATED MONOMER | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1982-06-08 | — | — | US | disclosed |
| US-3932420-A | Process for the preparation of glaziovine | ROUSSEL-UCLAF (FR) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071013-A1 | COMPOSITION CONTAINING FLUORINE-CONTAINING POLYMER, METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER, AND ULTRAVIOLET LIGHT-EMITTING ELEMENT LENS CONTAINING FLUORINE-CONTAINING POLYMER | PFN1, PF4, F9 | CES2 587/4885CES1 399/4885HDAC8 4258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.